Current and former FDA staff said the degree of involvement of political officials in nitty-gritty regulatory matters, from autism to vaccines, is unprecedented.
NHANES has collected data on eating patterns, diabetes and other common diseases for decades.
The company announced that it has raised $5.4 million to develop its platform and expand its base of customers.
Biomarker-based diagnoses are transforming the experiences of living with cognitive impairments — and sometimes having unexpected results.
The move makes Lyra the largest company to launch a generative artificial intelligence product as a part of ongoing therapy treatment.
The deal points to persistent heightened attention to obesity drugs, even after multiple years of activity and some clinical disappointments.
There’s a long history of employing euphemisms around animal research: Animals are supplies, tools, or specimens.
